Data is valuable currency to your biopharmaceutical company. It can tell you how well your new specialty drug is working for patients—and point out ways to make it work even better.
Editor's Note: This article first appeared on McKesson's website.
The best way to gather this data is by partnering with a specialty pharmacy. In this blog post, McKesson’s expert Ann Steagall shares how to use specialty pharmacy data to ensure your therapy’s clinical and financial success. To read the full post, click here.